Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5- and 10-year survivors

  • Chua T
  • Saxena A
  • Chu F
 et al. 
  • 20


    Mendeley users who have this article in their library.
  • 24


    Citations of this article.


Hepatic resection of colorectal liver metastases (CLM) is now regarded the standard of care. Evaluation of true long-term survivors will demonstrate the curative potential of this therapy with cure being defined as actual 10-year survival versus a satisfactory oncological outcome of 5-year survival. Limited data exists on outcomes of patients beyond 5 years. Studying the rates of cure and predictive factors for cure are essential to define the true benefit of this therapy.

Author-supplied keywords

  • colorectal cancer
  • cure
  • hepatectomy
  • liver metastasis
  • long-term survival

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Terence C. Chua

  • Akshat Saxena

  • Francis Chu

  • Jing Zhao

  • David L. Morris

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free